سبحان دارو

دسبحان | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 21,720 1.99
Close Price: 21,570

Cash Flow

2026/04/07
Fiscal Year 2025/12/2112 Month / Audited
2026/04/06
Fiscal Year 2025/12/2112 Month

Cash Generated from Operations

2.973 Trillion4.177 Trillion

Income Taxes Paid

-674.047 Billion-674.047 Billion

Net Cash Flow from Operating Activities

2.299 Trillion3.503 Trillion

Proceeds from Sale of Property, Plant and Equipment

6.078 Billion6.078 Billion

Purchases of Property, Plant and Equipment

-1.982 Trillion-1.982 Trillion

Purchases of Intangible Assets

-1.355 Billion-1.355 Billion

Proceeds from Sale of Long-Term Investments

701.059 Billion687.266 Billion

Cash Paid to Acquire Long-Term Investments

-13.793 Billion-

Cash Received from Income on Other Investments

238.37 Billion238.37 Billion

Net Cash Flow from Investing Activities

-1.051 Trillion-1.051 Trillion

Net Cash Flow before Financing Activities

1.248 Trillion2.451 Trillion

دریافت های نقدی حاصل از افزايش سرمایه

678.489 Billion678.489 Billion

Proceeds from Sale of Treasury Shares

237.026 Billion237.026 Billion

Purchases of Treasury Shares

-141.326 Billion-141.326 Billion

Cash Received from Borrowings

23.445 Trillion23.445 Trillion

Repayments of Borrowings (Principal)

-18.651 Trillion-19.994 Trillion

Interest Paid on Borrowings

-5.74 Trillion-5.74 Trillion

Dividends Paid

-489.503 Billion-489.503 Billion

Net Cash Flow from Financing Activities

-661.231 Billion-2.003 Trillion

Net Increase (Decrease) in Cash

586.275 Billion447.907 Billion

Cash at Beginning of Period

246.954 Billion246.954 Billion

Effect of Exchange Rate Changes

-31.644 Billion-344.512 Billion

Cash at End of Period

215.31 Billion-97.558 Billion

Non-Cash Transactions

3.844 Trillion2.502 Trillion